Repligen Corp
NASDAQ:RGEN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
108.89
174.24
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
RGEN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 160.67 USD,
Repligen Corp
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Repligen Corp
RGEN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether RGEN usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Repligen Corp.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Repligen Corp
Balance Sheet Decomposition
Repligen Corp
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 748.7m |
| Receivables | 149m |
| Other Current Assets | 198.8m |
| Non-Current Assets | 1.8B |
| PP&E | 313.1m |
| Intangibles | 1.5B |
| Other Non-Current Assets | 6m |
| Current Liabilities | 131.1m |
| Accounts Payable | 29.4m |
| Accrued Liabilities | 78.1m |
| Other Current Liabilities | 23.6m |
| Non-Current Liabilities | 709.5m |
| Long-Term Debt | 537.9m |
| Other Non-Current Liabilities | 171.6m |
Free Cash Flow Analysis
Repligen Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Repligen Corp
|
Revenue
|
707.9m
USD
|
|
Cost of Revenue
|
-342.7m
USD
|
|
Gross Profit
|
365.2m
USD
|
|
Operating Expenses
|
-318.6m
USD
|
|
Operating Income
|
46.6m
USD
|
|
Other Expenses
|
-44.8m
USD
|
|
Net Income
|
1.7m
USD
|
RGEN Profitability Score
Profitability Due Diligence
Repligen Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Repligen Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
RGEN Solvency Score
Solvency Due Diligence
Repligen Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Repligen Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RGEN Price Targets Summary
Repligen Corp
According to Wall Street analysts, the average 1-year price target for
RGEN
is 191.72 USD
with a low forecast of 161.6 USD and a high forecast of 231 USD.
Dividends
Current shareholder yield for
RGEN is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RGEN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 160.67 USD,
Repligen Corp
is
hidden
.